BR112017000359A2 - combinação de pregabalina e meloxicam para o tratamento de dor neuropática - Google Patents
combinação de pregabalina e meloxicam para o tratamento de dor neuropáticaInfo
- Publication number
- BR112017000359A2 BR112017000359A2 BR112017000359-7A BR112017000359A BR112017000359A2 BR 112017000359 A2 BR112017000359 A2 BR 112017000359A2 BR 112017000359 A BR112017000359 A BR 112017000359A BR 112017000359 A2 BR112017000359 A2 BR 112017000359A2
- Authority
- BR
- Brazil
- Prior art keywords
- pregabalin
- treatment
- neuropathic pain
- meloxicam
- combination
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title 1
- 229960001929 meloxicam Drugs 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title 1
- 229960001233 pregabalin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXMX/A/2014/008336 | 2014-07-07 | ||
MX2014008336A MX2014008336A (es) | 2014-07-07 | 2014-07-07 | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
PCT/IB2015/055127 WO2016005897A1 (en) | 2014-07-07 | 2015-07-07 | Combination of pregabalin and meloxicam for the treatment of neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017000359A2 true BR112017000359A2 (pt) | 2018-06-26 |
Family
ID=53938368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017000359-7A BR112017000359A2 (pt) | 2014-07-07 | 2015-07-07 | combinação de pregabalina e meloxicam para o tratamento de dor neuropática |
Country Status (5)
Country | Link |
---|---|
BR (1) | BR112017000359A2 (pt) |
CO (1) | CO2017001076A2 (pt) |
MX (1) | MX2014008336A (pt) |
PE (1) | PE20171140A1 (pt) |
WO (1) | WO2016005897A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11590094B2 (en) | 2017-09-28 | 2023-02-28 | Nevakar Injectables Inc. | Fixed dose combination formulations for treating pain |
MX2019008467A (es) * | 2019-07-16 | 2019-11-07 | Federico Amezcua Amezcua | Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico. |
CN112353767A (zh) * | 2020-11-16 | 2021-02-12 | 海南锦瑞制药有限公司 | 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6129907A (en) | 1999-08-04 | 2000-10-10 | Colgate Palmolive Company | Stable hydrogenated lupulone antibacterial oral compositions |
WO2003066040A1 (fr) | 2002-02-05 | 2003-08-14 | Ajinomoto Co.,Inc. | Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n |
DE10331305A1 (de) | 2003-07-10 | 2005-02-17 | Siemens Ag | Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht |
WO2006123247A2 (en) | 2005-05-20 | 2006-11-23 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
CA2701838A1 (en) | 2007-10-09 | 2009-04-16 | Merck Patent Gmbh | Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
MX2010005680A (es) | 2007-11-23 | 2010-12-21 | Protect Pharmaceutical Corp | Composiciones de tapentadol. |
MX336979B (es) | 2011-12-16 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion farmaceutica antineuritica y composiciones. |
-
2014
- 2014-07-07 MX MX2014008336A patent/MX2014008336A/es unknown
-
2015
- 2015-07-07 PE PE2017000033A patent/PE20171140A1/es unknown
- 2015-07-07 WO PCT/IB2015/055127 patent/WO2016005897A1/en active Application Filing
- 2015-07-07 BR BR112017000359-7A patent/BR112017000359A2/pt not_active Application Discontinuation
-
2017
- 2017-02-06 CO CONC2017/0001076A patent/CO2017001076A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20171140A1 (es) | 2017-08-09 |
MX2014008336A (es) | 2016-01-07 |
WO2016005897A1 (en) | 2016-01-14 |
CO2017001076A2 (es) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2769863T8 (es) | 7-hidroxi-cannabidivarín (7-OH-CBDV) para usar en el tratamiento de la epilepsia | |
BR112017011771A2 (pt) | métodos e composições para o tratamento de câncer | |
BR112016021682A2 (pt) | cenicriviroc para o tratamento da fibrose | |
BR112016027041A2 (pt) | Combinações farmacêuticas para tratamento do câncer | |
BR112016022976A2 (pt) | Métodos para o tratamento de hcv | |
BR112017024253A2 (pt) | métodos de tratamento de inflamação ou dor neuropática. | |
ZA201802498B (en) | Ozonolysis for activation of compounds and degradation of ozone | |
IL262825A (en) | Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment | |
DK3191103T3 (da) | Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner | |
HK1249865B (zh) | 疼痛的治療 | |
HK1244711A1 (zh) | Hmgb1介導的炎症的治療 | |
BR112016026369A2 (pt) | combinações de formoterol e budesonida para tratamento de copd. | |
DK3326635T3 (da) | Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod | |
BR112017000359A2 (pt) | combinação de pregabalina e meloxicam para o tratamento de dor neuropática | |
GB2548491B (en) | Treatment of fluids | |
IL250594A0 (en) | The composition for the treatment of nerve diseases and/or neuropathic pain | |
IL266243A (en) | Use of senicapoc for the treatment of neuropathic pain | |
HK1252359A1 (zh) | 用於治療疼痛的曲唑酮和加巴噴丁的組合 | |
BR112016029238A2 (pt) | método e aparelhos para fornecer uma solução para o tratamento de sangue. | |
GB201411616D0 (en) | Diagnosis and treatment of neurodegenerative disorders | |
GB201603755D0 (en) | Treatment of hypothyroidism | |
GB201603752D0 (en) | Treatment of hypothyroidism | |
ES1113580Y (es) | Dispositivo dental para el tratamiento de la onicofagia | |
SG10201913141UA (en) | Treatment of alphavirus-induced inflammation | |
ES1165233Y (es) | Dispositivo para el tratamiento de olores desagradables |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. PAGAR RESTAURACAO. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2703 DE 25/10/2022 POR TER SIDO INDEVIDA, UMA VEZ QUE O RECOLHIMENTO DA 7A ANUIDADE FOI EFETUADO EM 09/08/2021, ATRAVES DA GRU 29409161938157370. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |